Get started
Author

Isaivani Jayachandran

Sestrin2 regulates monocyte activation through AMPK‐mTOR nexus under high‐glucose and dyslipidemic conditions
2018 · Saravanakumar Sundararajan, Isaivani Jayachandran, et al. · Journal of Cellular Biochemistry · 47
Decreased Sestrin levels in patients with type 2 diabetes and dyslipidemia and their association with the severity of atherogenic index
2020 · S. Sundararajan, I. Jayachandran, et al. · Journal of Endocrinological Investigation · 33
Asymmetric dimethylarginine (ADMA) accelerates renal cell fibrosis under high glucose condition through NOX4/ROS/ERK signaling pathway
2020 · Isaivani Jayachandran, Saravanakumar Sundararajan, et al. · Scientific Reports · 28
PDF
Association of circulatory asymmetric dimethylarginine (ADMA) with diabetic nephropathy in Asian Indians and its causative role in renal cell injury
2017 · Isaivani Jayachandran, Saravanakumar Sundararajan, et al. · Clinical Biochemistry · 21
Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway in Obese and Diabetic Rats
2023 · Saravanakumar Sundararajan, Isaivani Jayachandran, et al. · Journal of Lipid and Atherosclerosis · 6
IDF21-0158 Aegeline mitigates high glucose induced renal cell fibrosis by alleviating ROS generation & augmenting hydrogen sulphide
2022 · S. Venkatesan, I. Jayachandran, et al. · Diabetes Research and Clinical Practice · 3
PDF
IDF21-0159 Asymmetric Dimethylarginine and 20-Hydroxyeicosatetraenoic Acid – A lethal combo in diabetic kidney disease
2022 · I. Jayachandran, S. Sundararajan, et al. · Diabetes Research and Clinical Practice
Role of sestrin2 in the regulation of ER stress and pro-inflammation under diabetes with dyslipidemia
2020 · Saravanakumar Sundararajan, Isaivani Jayachandran, et al. · Indian Journal of Inflammation Research
Works count: 8
Citation count: 138
H-index: 5
I10-index: 4
Year
Topic
Type